John T. Cahill Sells 8,000 Shares of Colgate-Palmolive Company (NYSE:CL) Stock

Colgate-Palmolive Company (NYSE:CL) Director John T. Cahill sold 8,000 shares of Colgate-Palmolive stock in a transaction on Thursday, July 27th. The stock was sold at an average price of $72.47, for a total transaction of $579,760.00. Following the completion of the transaction, the director now directly owns 31,786 shares of the company’s stock, valued at $2,303,531.42. The sale was disclosed in a document filed with the SEC, which can be accessed through this link.

Colgate-Palmolive Company (NYSE CL) traded down 0.03% during trading on Thursday, hitting $71.55. 2,567,901 shares of the company traded hands. The firm has a market cap of $63.02 billion, a price-to-earnings ratio of 26.59 and a beta of 0.80. Colgate-Palmolive Company has a 52-week low of $63.43 and a 52-week high of $77.27. The company’s 50-day moving average is $73.08 and its 200 day moving average is $72.72.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, July 21st. The company reported $0.72 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.72. Colgate-Palmolive had a net margin of 15.83% and a return on equity of 3,121.95%. The firm had revenue of $3.83 billion for the quarter, compared to analyst estimates of $3.89 billion. During the same period last year, the firm posted $0.70 EPS. Colgate-Palmolive’s quarterly revenue was down .5% on a year-over-year basis. On average, equities analysts anticipate that Colgate-Palmolive Company will post $2.89 earnings per share for the current year.

The business also recently announced a quarterly dividend, which will be paid on Tuesday, August 15th. Shareholders of record on Tuesday, July 18th will be given a dividend of $0.40 per share. The ex-dividend date of this dividend is Friday, July 14th. This represents a $1.60 annualized dividend and a dividend yield of 2.24%. Colgate-Palmolive’s payout ratio is currently 59.48%.

ILLEGAL ACTIVITY NOTICE: This report was first posted by [[site]] and is the property of of [[site]]. If you are accessing this report on another publication, it was stolen and reposted in violation of U.S. & international copyright laws. The correct version of this report can be read at [[permalink]].

Several large investors have recently modified their holdings of the company. Blue Chip Partners Inc. increased its position in Colgate-Palmolive by 0.4% in the first quarter. Blue Chip Partners Inc. now owns 1,805 shares of the company’s stock valued at $132,000 after buying an additional 8 shares during the period. Cue Financial Group Inc. increased its position in Colgate-Palmolive by 0.3% in the second quarter. Cue Financial Group Inc. now owns 4,854 shares of the company’s stock valued at $360,000 after buying an additional 14 shares during the period. Alpha Windward LLC increased its position in Colgate-Palmolive by 0.6% in the first quarter. Alpha Windward LLC now owns 2,829 shares of the company’s stock valued at $207,000 after buying an additional 18 shares during the period. Cornerstone Financial Partners LLC increased its position in Colgate-Palmolive by 0.5% in the second quarter. Cornerstone Financial Partners LLC now owns 3,813 shares of the company’s stock valued at $282,000 after buying an additional 19 shares during the period. Finally, Northstar Group Inc. increased its position in Colgate-Palmolive by 0.4% in the first quarter. Northstar Group Inc. now owns 4,850 shares of the company’s stock valued at $356,000 after buying an additional 20 shares during the period. Institutional investors own 73.85% of the company’s stock.

Several equities research analysts have recently commented on CL shares. Jefferies Group LLC started coverage on shares of Colgate-Palmolive in a report on Tuesday, April 18th. They issued a “hold” rating and a $78.00 price target for the company. Royal Bank Of Canada restated a “hold” rating and issued a $74.00 price target on shares of Colgate-Palmolive in a report on Monday, April 24th. UBS AG restated a “neutral” rating and issued a $78.00 price target (down previously from $79.00) on shares of Colgate-Palmolive in a report on Tuesday, May 2nd. Zacks Investment Research lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Wednesday, May 3rd. Finally, Vetr lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and set a $76.67 price target for the company. in a report on Wednesday, May 17th. Two investment analysts have rated the stock with a sell rating, twelve have given a hold rating and two have given a buy rating to the company. Colgate-Palmolive presently has an average rating of “Hold” and an average price target of $75.82.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.